Kidney Week 2013: Late breaking oral abstracts–BEACON trial
Late breaking oral abstracts– BEACON trial Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease Glenn Chertow, MD—Stanford The BEACON trial [...]
Copyright © 2026 Powered by WordPress.com.